About us Contacts Drug interactions: 390 212
Drug search by name

Bromocriptine (Cycloset) and PCE Dispertab

Determining the interaction of Bromocriptine (Cycloset) and PCE Dispertab and the possibility of their joint administration.

Check result:
Bromocriptine (Cycloset) <> PCE Dispertab
Relevance: 10.10.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using bromocriptine together with erythromycin may increase the effects of bromocriptine. Contact your doctor if you experience nausea, vomiting, constipation, sweating, pale skin, dizziness, drowsiness, yawning, confusion, hallucinations, muscle movements you cannot control, or loss of balance or coordination. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: Certain macrolide antibiotics may decrease the hepatic metabolism of bromocriptine. The proposed mechanism of the interaction is inhibition of CYP450 3A4. High bromocriptine plasma levels have been associated with dyskinesia, particularly in the elderly receiving bromocriptine for the treatment of symptoms of Parkinson's disease.

MANAGEMENT: Patients should be monitored for signs of toxicity, including headache, hypotension, nausea, and dyskinesia. A reduction in bromocriptine dosage may be necessary. Some authorities suggest that the bromocriptine dose may need to be reduced by up to 50% in order to avoid toxicity. Although clinical data are lacking, some manufacturers advise that when high bromocriptine levels are observed consideration should be given to the increased risk of dyskinesia.

References
  • Periti P, Mazzei T, Mini E, Novelli A "Pharmacokinetic drug interactions of macrolides." Clin Pharmacokinet 23 (1992): 106-31
  • von Rosenstiel NA, Adam D "Macrolide antibacterials. Drug interactions of clinical significance." Drug Saf 13 (1995): 105-22
  • "Product Information. Parlodel (bromocriptine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  • Nelson MV, Berchou RC, Kareti D, Le Witt PA "Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptine." Clin Pharmacol Ther 47 (1990): 694-7
Bromocriptine (Cycloset)

Generic Name: bromocriptine

Brand name: Parlodel, Cycloset

Synonyms: Bromocriptine

PCE Dispertab

Generic Name: erythromycin

Brand name: EES. Granules, EES-400 Filmtab, EryPed 200, EryPed 400, Ery-Tab, Erythrocin Lactobionate, Erythrocin Stearate Filmtab, PCE Dispertab, E. E. S, EryPed, Erythrocin, Erythromycin Filmtabs, Erythromycin Lactobionate - IV

Synonyms: PCE Dispertab (Oral), PCE, PCE (Oral)

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle